238 related articles for article (PubMed ID: 33597645)
61. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
Velasco M; O'Sullivan C; Sheridan GK
Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
[TBL] [Abstract][Full Text] [Related]
62. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
Nikolaou A; Ninou I; Kokotou MG; Kaffe E; Afantitis A; Aidinis V; Kokotos G
J Med Chem; 2018 Apr; 61(8):3697-3711. PubMed ID: 29620892
[TBL] [Abstract][Full Text] [Related]
63. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
64. Benzoxaboroles-Novel Autotaxin Inhibitors.
Kraljić K; Jelić D; Žiher D; Cvrtila A; Dragojević S; Sinković V; Mesić M
Molecules; 2019 Sep; 24(19):. PubMed ID: 31547058
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke.
Bitar L; Uphaus T; Thalman C; Muthuraman M; Gyr L; Ji H; Domingues M; Endle H; Groppa S; Steffen F; Koirala N; Fan W; Ibanez L; Heitsch L; Cruchaga C; Lee JM; Kloss F; Bittner S; Nitsch R; Zipp F; Vogt J
Sci Transl Med; 2022 Apr; 14(641):eabk0135. PubMed ID: 35442704
[TBL] [Abstract][Full Text] [Related]
67. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure.
Trovato FM; Zia R; Artru F; Mujib S; Jerome E; Cavazza A; Coen M; Wilson I; Holmes E; Morgan P; Singanayagam A; Bernsmeier C; Napoli S; Bernal W; Wendon J; Miquel R; Menon K; Patel VC; Smith J; Atkinson SR; Triantafyllou E; McPhail MJW
J Hepatol; 2023 Mar; 78(3):558-573. PubMed ID: 36370949
[TBL] [Abstract][Full Text] [Related]
68. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
[TBL] [Abstract][Full Text] [Related]
69. Changes in pain behavior and glial activation in the spinal dorsal horn after pulsed radiofrequency current administration to the dorsal root ganglion in a rat model of lumbar disc herniation: laboratory investigation.
Cho HK; Cho YW; Kim EH; Sluijter ME; Hwang SJ; Ahn SH
J Neurosurg Spine; 2013 Aug; 19(2):256-63. PubMed ID: 23746090
[TBL] [Abstract][Full Text] [Related]
70. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
71. The effect of selective serotonin reuptake inhibitor (SSRI) on pain-related behavior in a rat model of neuropathic pain.
Saito H; Wakai J; Sekiguchi M; Kikuchi S; Konno S
Eur Spine J; 2014 Nov; 23(11):2401-9. PubMed ID: 24898312
[TBL] [Abstract][Full Text] [Related]
72. A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis.
Booijink R; Salgado-Polo F; Jamieson C; Perrakis A; Bansal R
EMBO Mol Med; 2022 Sep; 14(9):e16333. PubMed ID: 35833384
[TBL] [Abstract][Full Text] [Related]
73. Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex.
Katakai T; Kondo N; Ueda Y; Kinashi T
J Immunol; 2014 Jul; 193(2):617-26. PubMed ID: 24935929
[TBL] [Abstract][Full Text] [Related]
74. The ATX-LPA Axis Regulates Vascular Permeability during Cerebral Ischemic-Reperfusion.
Bhattarai S; Sharma S; Subedi U; Ara H; Shum A; Milena M; Bhuiyan MS; Kidambi S; Sun H; Miriyala S; Panchatcharam M
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456953
[TBL] [Abstract][Full Text] [Related]
75. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
76. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
[TBL] [Abstract][Full Text] [Related]
77. Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds.
Norman DD; Ibezim A; Scott WE; White S; Parrill AL; Baker DL
Bioorg Med Chem; 2013 Sep; 21(17):5548-60. PubMed ID: 23816044
[TBL] [Abstract][Full Text] [Related]
78. The Wnt/
Zhang Y; Zhao D; Li X; Gao B; Sun C; Zhou S; Ma Y; Chen X; Xu D
Neural Plast; 2021; 2021():6680192. PubMed ID: 33959159
[TBL] [Abstract][Full Text] [Related]
79. Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.
Fells JI; Lee SC; Fujiwara Y; Norman DD; Lim KG; Tsukahara R; Liu J; Patil R; Miller DD; Kirby RJ; Nelson S; Seibel W; Papoian R; Parrill AL; Baker DL; Bittman R; Tigyi G
Mol Pharmacol; 2013 Sep; 84(3):415-24. PubMed ID: 23793291
[TBL] [Abstract][Full Text] [Related]
80. Comparison of neuropathic pain and neuronal apoptosis following nerve root or spinal nerve compression.
Sekiguchi M; Sekiguchi Y; Konno S; Kobayashi H; Homma Y; Kikuchi S
Eur Spine J; 2009 Dec; 18(12):1978-85. PubMed ID: 19543754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
